https://www.selleckchem.com/pr....oducts/propionyl-l-c
Six articles covering five treatment studies were included. Studies yielded mixed findings likely due to large variability in methodology, including lack of standardized dosing paradigms, modes of use, and duration of trial. The current quality and level of evidence is insufficient to draw reliable conclusions of the efficacy of cannabis upon SCI-related pain itensity. We identify specific limitations of past studies and present guidelines for future research. ClinicalTrials.gov identifier Nct01606202.. The c
Like
Comment
Share
